4.6 Article

AMPK beta 1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 285, Issue 1, Pages 115-122

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M109.056762

Keywords

-

Funding

  1. Australian Research Council
  2. National Health and Medical Research Council
  3. Diabetes Australia Research Trust
  4. National Heart Foundation of Australia

Ask authors/readers for more resources

The AMP-activated protein kinase (AMPK) is an alpha beta gamma heterotrimer that regulates appetite and fuel metabolism. We have generated AMPK beta 1(-/-) mice on a C57Bl/6 background that are viable, fertile, survived greater than 2 years, and display no visible brain developmental defects. These mice have a 90% reduction in hepatic AMPK activity due to loss of the catalytic alpha subunits, with modest reductions of activity detected in the hypothalamus and white adipose tissue and no change in skeletal muscle or heart. On a low fat or an obesity-inducing high fat diet, beta 1(-/-) mice had reduced food intake, reduced adiposity, and reduced total body mass. Metabolic rate, physical activity, adipose tissue lipolysis, and lipogenesis were similar to wild type littermates. The reduced appetite and body mass of beta 1(-/-) mice were associated with protection from high fat diet-induced hyperinsulinemia, hepatic steatosis, and insulin resistance. We demonstrate that the loss of beta 1 reduces food intake and protects against the deleterious effects of an obesity-inducing diet.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available